Home › Funds › Blankinship & Foster, LLC › ABT

Blankinship & Foster, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Blankinship & Foster, LLC reported holding 12,064 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.24% of its reported portfolio and ranking #30 among its reported holdings. Blankinship & Foster, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)12.06K sh
Reported value held$1.19M
Portfolio Weight0.24%
First reportedQ3 2023
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Blankinship & Foster, LLC's ABT position evolved

Blankinship & Foster, LLC first disclosed a stake in ABT in Q3 2023 at 11,969 shares (US$1.2M). The position peaked in Q2 2025 at 12,034 shares, worth US$1.6M. Across 13 filings, Blankinship & Foster, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 12,064 shares valued at US$1.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.97K $1.16M New
Q4 2023 11.97K $1.32M Hold
Q1 2024 11.97K $1.36M Hold
Q2 2024 11.97K $1.24M Hold
Q3 2024 11.97K $1.36M Hold
Q4 2024 11.97K $1.35M Hold
Q1 2025 11.97K $1.59M Hold
Q2 2025 12.03K $1.64M Add
Q3 2025 12.06K $1.62M Hold
Q4 2025 12.05K $1.51M Hold
Q1 2026 12.05K $1.24M Hold
Q2 2026 12.04K $1.09M Hold
Q3 2026 12.06K $1.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Blankinship & Foster, LLC held ABT?

Blankinship & Foster, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Blankinship & Foster, LLC's current position in ABT?

As of Q3 2026, Blankinship & Foster, LLC holds 12.06K shares of ABT (ABBOTT LABORATORIES), valued at $1.19M, representing 0.24% of its reported portfolio and ranking #30.

Has Blankinship & Foster, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Blankinship & Foster, LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 12.03K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.